LQDA · Liquidia Corp
$74.44
+2.34 (+3.25%)
At close · Aug 14
Market Cap
$6.66B
Shares
89.51M
Liquidia Corp Earnings Call Transcripts
Every quarterly earnings call for Liquidia Corp (LQDA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼0.4%
$3.17M
−$9.09M
'22 Q3
22-11-08
▲66.8%
$5.36M
−$6.53M
'22 Q4
23-03-16
▲28.7%
$4.49M
−$11.74M
'23 Q1
23-05-04
▲22.2%
$4.79M
−$23.52M
'23 Q2
23-08-10
▲16.2%
$3.68M
−$15.79M
'23 Q3
23-11-07
▼15.5%
$4.53M
−$27.45M
'23 Q4
24-03-13
▼33.9%
$2.97M
−$30.08M
'24 Q1
24-05-14
▼23.5%
$3.66M
−$28.67M
'24 Q2
24-08-07
▲20.9%
$4.45M
−$31.03M
'24 Q3
24-11-13
▼35.6%
$2.92M
−$38.51M
'24 Q4
25-03-19
▲5%
$3.12M
−$38.37M
'25 Q1
25-05-08
▲141.5%
$8.84M
−$41.58M
'25 Q2
25-08-12
▲1121.7%
$54.34M
−$3.53M
'25 Q3
25-11-03
▲3054.6%
$92.02M
$14.55M
'25 Q4
26-03-05
▲4158.5%
$132.87M
$52.86M
'26 Q1
26-05-11
LATEST
▲1842.7%
$171.68M
$74.72M
'26 Q2
26-08-12
Earnings call
FY26 · Q2
2026-08-12
Liquidia Corp Q2 FY2026 Earnings Call
Confident tone
L606 Pipeline Development
Community Setting Penetration
ASCENT Clinical Data in PH-ILD
Revenue
$171.68M
▲ 1842.7% YoY Diluted EPS
$0.74
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-03
2026 Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-11
Liquidia Corp Q1 FY2026 Earnings Call
Confident tone
YUTREPIA commercial launch momentum
Sales force expansion and market education
Pipeline and label expansion studies
Revenue
$132.87M
▲ 4158.5% YoY Diluted EPS
$0.52
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Liquidia Corp Q4 FY2025 Earnings Call
Confident tone
YUTREPIA Commercial Launch
Disease Area Expansion
Pipeline and Clinical Expansion
Revenue
$92.02M*
▲ 3054.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Liquidia Corp Q3 FY2025 Earnings Call
Confident tone
YUTREPIA commercial launch performance
Market opportunity sizing
Hatch-Waxman patent litigation risk
Revenue
$54.34M
▲ 1121.7% YoY Diluted EPS
$-0.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Liquidia Corp Q2 FY2025 Earnings Call
Confident tone
YUTREPIA launch uptake
Product differentiation vs Tyvaso
ASCENT study in PH-ILD
Revenue
$8.84M
▲ 141.5% YoY Diluted EPS
$-0.49
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Liquidia Corp Q1 FY2025 Earnings Call
Confident tone
YUTREPIA launch preparation
ASCENT study in PH-ILD
Commercial readiness and sales force
Revenue
$3.12M
▲ 5% YoY Diluted EPS
$-0.45
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-19
Liquidia Corp Q4 FY2024 Earnings Call
Revenue
$2.92M
▼ 35.6% YoY Diluted EPS
$-0.45
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Liquidia Corp Q3 FY2024 Earnings Call
Revenue
$4.45M
▲ 20.9% YoY Diluted EPS
$-0.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Liquidia Corp Q2 FY2024 Earnings Call
Revenue
$3.66M
▼ 23.5% YoY Diluted EPS
$-0.38
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Liquidia Corp Q1 FY2024 Earnings Call
Revenue
$2.97M
▼ 33.9% YoY Diluted EPS
$-0.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-13
Liquidia Corp Q4 FY2023 Earnings Call
Confident tone
Litigation and patent matters
Market opportunity
FDA approval of YUTREPIA
Revenue
$4.53M
▼ 15.5% YoY Diluted EPS
$-0.43
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Liquidia Corp Q3 FY2023 Earnings Call
Revenue
$3.68M
▲ 16.2% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Liquidia Corp Q2 FY2023 Earnings Call
Revenue
$4.79M
▲ 22.2% YoY Diluted EPS
$-0.36
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Liquidia Corp Q1 FY2023 Earnings Call
Revenue
$4.49M
▲ 28.7% YoY Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Liquidia Corp Q4 FY2022 Earnings Call
Revenue
$5.36M*
▲ 66.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Liquidia Corp Q3 FY2022 Earnings Call
Revenue
$3.17M
▼ 0.4% YoY Diluted EPS
$-0.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Liquidia Corp Q2 FY2022 Earnings Call
Revenue
$3.92M
▲ 16.1% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Liquidia Corp Q1 FY2022 Earnings Call
Revenue
$3.49M
▲ 13.2% YoY Diluted EPS
$-0.30
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-18
Liquidia Corp Q4 FY2021 Earnings Call
Revenue
$3.21M*
▲ 334.5% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q2
2021-06-30
Liquidia Corp Q2 FY2021 Earnings Call
Revenue
$3.38M
Diluted EPS
$-0.13
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Liquidia Corp Q1 FY2021 Earnings Call
Revenue
$3.08M
Diluted EPS
$-0.21
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-23
Liquidia Corp Q4 FY2020 Earnings Call
Revenue
$739,628*
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Liquidia Corp Q3 FY2020 Earnings Call
Revenue
$
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Liquidia Corp Q2 FY2020 Earnings Call
Revenue
$
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Liquidia Corp Q1 FY2020 Earnings Call
Revenue
$
Audio
Transcript
Slides
8-K10-Q
Showing 1–26 of 26 earnings calls
Key facts
CIK
1819576
CUSIP
53635D202
13F (30d)
315 filings
314 filers
Visit website
Investor relations